A D S Diagnostics Ltd

AGM details

• Held on 29 September 2026 via VC/OAVM; venue deemed at registered office.
• Meeting lasted 11:30 to 11:40 a.m.; remote e-voting 26–28 September 2026.
• Voting entitlement cut-off set at 22 September 2026.

Ordinary resolutions

• Adoption of audited accounts and Directors' and Auditors' report.
• Re-appointment of Dr. Radhika Sehgal as Director, retiring by rotation.
• Dividend on equity shares for FY2025-26 declared.
• Ratification of appointment of Statutory Auditors to hold until next AGM.

Special resolutions

• Re-appointment of Girish Sareen as Independent Director for one year.
• Re-appointment of Sunil Jasuja as Independent Director for one year.
• Re-appointment of Uday Walia as Independent Director for five years.
• Regularisation of Abhay Singh as Independent Director for five years.
• Appointment of Nitesh Singh & Associates as Secretarial Auditor for 2026–31.

Directors & governance changes

• Dr. Radhika Sehgal re-appointed as Director (retiring by rotation).
• Girish Sareen, Sunil Jasuja, Uday Walia re-appointed as Independent Directors.
• Abhay Singh regularised as Independent Director.

Auditors & secretarial

• Statutory Auditor ratified to hold office till 2027.
• Secretarial Auditor appointed for 2026–31 for five years.

Voting results

• All resolutions passed with requisite majority.
• Scrutiniser: Nitesh Singh; results to be communicated separately.

Dividend and record dates

• Final dividend of Rs 1.20 per equity share approved by the Board for FY2026, subject to shareholder approval.
• Book closure from 23 Sep 2026 to 29 Sep 2026 for dividend declaration and AGM.
• Record date for dividend: 26 Sep 2026; e-voting eligibility: 22 Sep 2026.
• AGM date: 29 Sep 2026.

Governance actions

• Board approved and recommended the final dividend on 29 May 2026.
• Dividend remains conditional on shareholder approval at the 41st AGM.

Closure and AGM cut-off

• Register of Members and Share Transfer Books closed 23 September to 28 September 2026 (inclusive).
• AGM on 29 September 2026 via video conferencing; 22 September 2026 is remote voting cut-off.
• Entitlement to Final Dividend for FY 2025-26 to be ascertained if declared at AGM.

Financial results and metrics

• Board approved unaudited standalone results for quarter ended 30 June 2026.
• Revenue from operations ₹328.21 Lakh; other income ₹23.33 Lakh; total ₹351.54 Lakh.
• Net profit after tax ₹3.22 Lakh; basic/diluted EPS ₹0.15.
• Audit committee reviewed results; results prepared under Ind AS 34; single segment business.
• Independent auditor's review: no material misstatement observed.
• No dividend, capital raising, buyback, or major investments announced.
• Company has one reportable segment under Ind AS 108.

Meeting Details

• Date: 13 August 2026.
• Location: Registered Office or via Zoom.

Key Agenda Items

• To consider and approve Audited financial results for quarter-ended 30 June 2026.
• To consider and transact any other business, if any, with the permission of the Chairman.

Other Notes

• No additional material notes disclosed in this filing.

Financial results approved

• Board approved audited standalone financial results for quarter and year ended 31 March 2026.

Dividend recommendation

• Board recommended 12% dividend, Rs. 1.20 per equity share of face value Rs. 10, subject to shareholder approval.

Auditor conclusion

• Auditor issued unmodified opinion on annual results and no material misstatement noted in quarter review.

Meeting Details

• Board meeting scheduled for Friday, 29 May 2026.
• Location: Registered Office or through Zoom application.

Key Agenda Items

• Consider and approve audited financial results for quarter ended 31 March 2026.

Other Notes

• No other material investor-relevant items disclosed.